CBD Inhalation Cuts Neuroinflammation in Alzheimer Mice
SkimNews Take
CBD's potential to modulate neuroinflammation suggests a broader therapeutic strategy for Alzheimer's, moving beyond direct amyloid or tau targeting to address systemic immune responses contributing to neurodegeneration.
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- CBD inhaled by Alzheimer’s mouse models lowered activity of several neuroinflammatory regulators and reduced proinflammatory molecules.
- Babak Baban of Augusta University led the study, which was published in the journal eNeuro.
- eNeuro published the study showing that CBD interacts with specific immune pathways, indicating multi‑system influence on Alzheimer’s pathology.
- Augusta University researchers concluded that chronic autoinflammation, not just plaques and tangles, is a core driver of Alzheimer’s disease.
Why it matters: Alzheimer’s patients gain a new therapeutic target, while researchers pivot toward anti‑inflammatory strategies, reshaping drug development pipelines for the healthcare system and accelerating clinical trials.
Ask SkimNews
